O'Shaughnessy Asset Management’s ADMA Biologics ADMA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,582	Closed	-$211K	–	2652
2025 Q4	$211K	Buy	11,582 +94	+0.8%	+$1.58K	﹤0.01%	1957
2025 Q3	$168K	Sell	11,488 -4,300	-27%	-$73.7K	﹤0.01%	1986
2025 Q2	$287K	Sell	15,788 -2,802	-15%	-$57.1K	﹤0.01%	1662
2025 Q1	$369K	Sell	18,590 -4,350	-19%	-$75.2K	﹤0.01%	1467
2024 Q4	$393K	Buy	22,940 +550	+2%	+$10.3K	﹤0.01%	1388
2024 Q3	$367K	Buy	22,390 +9,205	+70%	+$143K	﹤0.01%	1370
2024 Q2	$147K	Buy	+13,185	New	+$111K	﹤0.01%	1594

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

O'Shaughnessy Asset Management's ADMA Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 11,582 shares — an estimated $211K sold.

O'Shaughnessy Asset Management first reported a position in ADMA in Q2 2024 and held it in 7 quarters. The position peaked at $393K in Q4 2024. 357 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

O'Shaughnessy Asset Management reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
O'Shaughnessy Asset Management sold 11,582 ADMA Biologics shares in Q1 2026, an estimated $211K.
O'Shaughnessy Asset Management first reported a position in ADMA Biologics in Q2 2024 and held it in 7 quarters.
O'Shaughnessy Asset Management's ADMA Biologics position peaked at $393K in Q4 2024.
357 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.